Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Drug Policy (Second Edition) - Ghana (GNDP; 2004; 37 pages)
View the documentPREFACE
View the documentACKNOWLEDGEMENT
View the documentLIST OF ACRONYMS
View the documentINTRODUCTION
View the documentGOAL
View the documentOBJECTIVES
View the documentSITUATIONAL ANALYSIS
Open this folder and view contents1.0 DRUG SELECTION
Open this folder and view contents2.0 DRUG PROCUREMENT, STORAGE AND DISTRIBUTION
Open this folder and view contents3.0 DRUG FINANCING
Open this folder and view contents4.0 QUALITY ASSURANCE
close this folder5.0 LOCAL MANUFACTURE OF PHARMACEUTICAL AND TRADITIONAL MEDICINAL PRODUCTS
View the document5.1 Preamble
View the document5.2 Objective
View the document5.3 Policy statement
Open this folder and view contents6.0 RATIONAL DRUG USE
Open this folder and view contents7.0 GLOBAL TRADE AND PHARMACEUTICALS
Open this folder and view contents8.0 EMERGING DISEASES AND PHARMACEUTICALS
Open this folder and view contents9.0 HUMAN RESOURCE DEVELOPMENT FOR DRUG MANAGEMENT
Open this folder and view contents10.0 TRADITIONAL MEDICINAL PRODUCTS
Open this folder and view contents11.0 RESEARCH AND DEVELOPMENT
Open this folder and view contents12.0 NATIONAL DRUG POLICY IMPLEMENTATION
View the documentANNEX A: DEFINITIONS
View the documentANNEX B: RELEVANT REGULATIONS ON PHARMACEUTICALS
 

5.3 Policy statement

5.3.1 A list of registered local drug and traditional medicine product manufacturers shall be compiled, published and reviewed by the FDB annually in accordance with the provisions of the existing laws.

5.3.2 Only drugs conforming to nationally accepted and/or internationally recognised quality standards shall be permitted to be manufactured and distributed in the country.

5.3.3 The regular and thorough inspection procedures for manufacturing and quality control facilities shall be instituted by the FDB.

5.3.4 The MOH through the FDB shall ensure that pharmaceutical companies institute product recall procedures. The FDB shall enforce the withdrawal from circulation of drug products, which have been shown by testing or demonstrated otherwise to be of unacceptable quality.

5.3.5 The manufacture, importation, exportation and distribution of counterfeit, substandard and expired raw materials and finished products shall not be permitted and shall be punishable by the provisions of the Food and Drugs Law 1992 (PNDCL 305B).

5.3.6 The Government shall support the private sector through various industrial funds and foreign grants available to it to develop the raw material base for the pharmaceutical and herbal industries.

5.3.7 The Government shall provide the needed finance and technical support to promote the development and growth of local pharmaceutical industries.

5.3.8 All local drug and traditional medicinal products shall comply with environmental laws of Ghana.

5.3.9 The export of locally manufactured pharmaceutical and medicinal products shall be encouraged and shall conform to local and international standards and specifications and be in accordance with existing laws and regulations.

to previous sectionto next section

Please provide your feedback English  |  French